ARTICLE | Clinical News
ALLP's DSMB review
March 16, 2000 8:00 AM UTC
Alliance Pharmaceutical (ALLP) said that after reviewing data from 165 patients, a Data Safety Monitoring Board (DSMB) recommended continuation of the company's North American Phase II/III trial of Li...